https://orcid.org/0000-0003-4479-2356
References
- Bajda M, Więckowska A, Hebda M, Guzior N, Sotriffer CA, Malawska B. 2013. Structure-based search for new inhibitors of cholinesterases. Int J Mol Sci. 14(3):5608–5632.
- Blaikie L, Kay G, Kong Thoo Lin P. 2019. Current and emerging therapeutic targets of Alzheimer's disease for the design of multi-target directed ligands. Medchemcomm. 10(12):2052–2072.
- Bortolami M, Rocco D, Messore A, Di Santo R, Costi R, Madia VN, Scipione L, Pandolfi F. 2021. Acetylcholinesterase inhibitors for the treatment of Alzheimer's disease - a patent review (2016-present). ).Expert Opin Ther Pat. 31(5):399–420.
- Chen X, Wehle S, Kuzmanovic N, Merget B, Holzgrabe U, Konig B, Sotriffer CA, Decker M. 2014. Acetylcholinesterase inhibitors with photoswitchable inhibition of β-amyloid aggregation. ACS Chem Neurosci. 5(5):377–389.
- Conlon JM, Mechkarska M, Lukic ML, Flatt PR. 2014. Potential therapeutic applications of multifunctional host-defense peptides from frog skin as anti-cancer, anti-viral, immunomodulatory, and anti-diabetic agents. Peptides. 57:67–77.
- Greig NH, Lahiri DK, Sambamurti K. 2002. Butyrylcholinesterase: an important new target in Alzheimer's disease therapy. Int Psychogeriatr. 14 (S1):77–91.
- Knez D, Coquelle N, Pislar A, Zakelj S, Jukic M, Sova M, Mravljak J, Nachon F, Brazzolotto X, Kos J, et al. 2018. Multi-target-directed ligands for treating Alzheimer's disease: Butyrylcholinesterase inhibitors displaying antioxidant and neuroprotective activities. Eur J Med Chem. 156:598–617.
- Knez D, Sova M, Košak U, Gobec S. 2017. Dual inhibitors of cholinesterases and monoamine oxidases for Alzheimer's disease. Future Med Chem. 9(8):811–832.
- Liu C, Hong J, Yang H, Wu J, Ma D, Li D, Lin D, Lai R. 2010. Frog skins keep redox homeostasis by antioxidant peptides with rapid radical scavenging ability. Free Radic Biol Med. 48(9):1173–1181.
- Spinelli R, Aimaretti F, Lopez J, Siano A. 2021. Amphibian skin extracts as source of bioactive multi-target agents against different pathways of Alzheimer's disease. Nat Prod Res. 35(4):686–689.
- Spinelli R, Sanchis I, Aimaretti FM, Attademo AM, Portela M, Humpola MV, Tonarelli GG, Siano AS. 2019. Natural multi-target inhibitors of cholinesterases and monoamine oxidase enzymes with antioxidant potential from skin extracts of Hypsiboas cordobae and Pseudis minuta (Anura: Hylidae). Chem Biodivers. 16(1):e1800472.
- Tyler M, Wassersug R, Smith B. 2007. How frogs and humans interact: Influences beyond habitat destruction, epidemics and global warming. Appl Herpetol. 4(1):1–18.
- Tyler MJ, Stone DJ, Bowie JH. 1992. A novel method for the release and collection of dermal, glandular secretions from the skin of frogs. J Pharmacol Tox Met. 28(4):199–200.
- Venkatraghavan V, Bron EE, Niessen WJ, Klein S, Alzheimer's Disease Neuroimaging Initiative 2019. Disease progression timeline estimation for Alzheimer's disease using discriminative event based modeling. Neuroimage. 186:518–532.